Lv1
68 积分 2026-01-03 加入
MRI-Based Quantification of Intratumoral Heterogeneity Predicts Response in Hepatocellular Carcinoma Treated with Atezolizumab-Bevacizumab and TACE/HAIC
3天前
已完结
T1 relaxation time analysis in predicting hepatic dysfunction and prognosis in patients with HCC undergoing transarterial chemoembolization
3天前
已完结
EXTH-13. COMBINED ANTI-ANGIOGENIC TREATMENT TO INCREASE INTRATUMORAL PERSISTENCE OF CAR T-CELLS IN LUNG CANCER BRAIN METASTASES
1个月前
已关闭
IMG-58. Radiomics can delineate lung cancer subtypes in metastatic lesions to the brain using magnetic resonance imaging
1个月前
已完结
Development and validation of a CT-based online calculator for prognosis and postoperative adjuvant transcatheter arterial chemoembolization benefit prediction in resected hepatocellular carcinoma: a multicenter retrospective cohort study
1个月前
已完结
IMG-58. Radiomics can delineate lung cancer subtypes in metastatic lesions to the brain using magnetic resonance imaging
1个月前
已完结
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)
2个月前
已完结
IKF-035/ABC-HCC: A phase IIIb, randomized, multicenter, open-label trial of atezolizumab plus bevacizumab versus transarterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinoma
2个月前
已关闭
Recent Advances in Embolic Agents for Transarterial Chemoembolization of Hepatocellular Carcinoma
2个月前
已完结
皖公网安备34019202002308
